LncRNA Information | ||||||
---|---|---|---|---|---|---|
ID | EL0972 | Name | NDM29 | Aliases | N/A | |
Species | Homo sapiens | Chromosome | N/A | Start site | N/A | |
End site | N/A | Chain | N/A | Exon NO. | N/A | |
Assembly | N/A | Class | N/A | NCBI accession | N/A | |
Ensembl | N/A | Sequence | N/A |
Disease | |||||||||
---|---|---|---|---|---|---|---|---|---|
Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source | ||
neuroblastoma | N/A | N/A | N/A | expression | In humans, ndm29 maps in a genomic region whose deletion has been shown to be involved in neuroblastoma development. | 16000168 | |||
neuroblastoma | qPCR etc. | cell lines (NB, NIE-115, SKNBE2 etc.) | up-regulated | expression | The synthesis of a pol III-transcribed noncoding (nc) RNA (NDM29) strongly restricts NB development by promoting cell differentiation, a drop of malignancy processes. NDM29 expression leads to NB cell differentiation. | 20581224 | LncRNADisease Lnc2Cancer | ||
Function (not disease relevant) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Methods | Sample/condition | Expression pattern | Dysfunction type | Description | PMID | Source | |||
RNA-seq, qRT-PCR | three different brain regions (cortex, white matter, and cerebellum) of human postmortem tissue | N/A | N/A | Thus, these 5 lncRNAs may be applicable as references for accurate normalisation of lncRNA profiling in multiple brain regions during long PMI, enabling the generation of highly reproducible datasets in lncRNA studies of the human brain. | 25528156 | ||||